Mythili Koneru - Feb 17, 2022 Form 4 Insider Report for Marker Therapeutics, Inc. (MRKR)

Role
Chief Medical Officer
Signature
/s/ Michael Loiacono, Attorney-in-Fact
Stock symbol
MRKR
Transactions as of
Feb 17, 2022
Transactions value $
$0
Form type
4
Date filed
2/22/2022, 04:07 PM
Next filing
Mar 1, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRKR Employee Stock Option (right to buy) Award $0 +160K $0.00 160K Feb 17, 2022 Common Stock 160K $0.46 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in equal monthly installments over a four year period commencing on March 17, 2022 subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.